Found: 8
Select item for more details and to access through your institution.
Serological and experimental studies in different forms of myasthenia gravis.
- Published in:
- Annals of the New York Academy of Sciences, 2018, v. 1413, n. 1, p. 143, doi. 10.1111/nyas.13592
- By:
- Publication type:
- Article
Effects of a polymorphism in the GFAP promoter on the age of onset and ambulatory disability in late-onset Alexander disease.
- Published in:
- Journal of Human Genetics, 2013, v. 58, n. 9, p. 635, doi. 10.1038/jhg.2013.83
- By:
- Publication type:
- Article
Anti-aquaporin 4 antibody binding character in clinical subtypes of neuromyelitis optica.
- Published in:
- Clinical & Experimental Neuroimmunology, 2012, v. 3, n. 3, p. 109, doi. 10.1111/j.1759-1961.2012.00031.x
- By:
- Publication type:
- Article
Very late onset neuromyelitis optica spectrum disorders.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 8, p. 2574, doi. 10.1111/ene.14901
- By:
- Publication type:
- Article
Autoantibodies in Japanese patients with ocular myasthenia gravis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Autoimmunity to ion channels in neurological diseases–Autoimmunity to aquaporin water channels.
- Published in:
- Neurology & Clinical Neuroscience, 2024, v. 12, n. 3, p. 137, doi. 10.1111/ncn3.12653
- By:
- Publication type:
- Article
Immunotherapy for ocular myasthenia gravis: an observational study in Japan.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231163819
- By:
- Publication type:
- Article
Immunotherapy for ocular myasthenia gravis: an observational study in Japan.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231163819
- By:
- Publication type:
- Article